Search Results - Meyling Cheok

Refine Results
  1. 1
    Pharmacogenetics in Acute Lymphoblastic Leukemia

    Pharmacogenetics in Acute Lymphoblastic Leukemia by Meyling Cheok, Nicolas Pottier, Leo Kager, William E. Evans

    Published 2008
    Get full text
    Revisão
    Save to List
    Saved in:
  2. 2
    CD38 in Hairy Cell Leukemia Is a Marker of Poor Prognosis and a New Target for Therapy

    CD38 in Hairy Cell Leukemia Is a Marker of Poor Prognosis and a New Target for Therapy by Nicolas Poret, Qiangwei Fu, Soizic Guihard, Meyling Cheok, Katie Miller, Gordon Zeng, Bruno Quesnel, Xavier Troussard, Sylvie Galiègue‐Zouitina, Carl Simon Shelley

    Published 2015
    Get full text
    Artigo
    Save to List
    Saved in:
  3. 3
    Folate pathway gene expression differs in subtypes of acute lymphoblastic leukemia and influences methotrexate pharmacodynamics

    Folate pathway gene expression differs in subtypes of acute lymphoblastic leukemia and influences methotrexate pharmacodynamics by Leo Kager, Meyling Cheok, Wenjian Yang, Gianluigi Zaza, Qing Cheng, John C. Panetta, Ching‐Hon Pui, James R. Downing, Mary V. Relling, William E. Evans

    Published 2005
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  4. 4
    Genetic Polymorphism of Inosine Triphosphate Pyrophosphatase Is a Determinant of Mercaptopurine Metabolism and Toxicity During Treatment for Acute Lymphoblastic Leukemia

    Genetic Polymorphism of Inosine Triphosphate Pyrophosphatase Is a Determinant of Mercaptopurine Metabolism and Toxicity During Treatment for Acute Lymphoblastic Leukemia by Gabriele Stocco, Meyling Cheok, Kristine R. Crews, Thierry Dervieux, Deborah French, D Pei, Wenjian Yang, Christopher H.K. Cheng, C-H Pui, MV Relling, Evans We

    Published 2008
    Get full text
    Artigo
    Save to List
    Saved in:
  5. 5
    Integrating rare genetic variants into DPYD pharmacogenetic testing may help preventing fluoropyrimidine-induced toxicity

    Integrating rare genetic variants into DPYD pharmacogenetic testing may help preventing fluoropyrimidine-induced toxicity by Romain Larrue, Sandy Fellah, Benjamin Hennart, Naoual Sabaouni, Nihad Boukrout, Cynthia Van der Hauwaert, Clément Delage, Meyling Cheok, Michaël Perrais, Christelle Cauffiez, Delphine Allorge, Nicolas Pottier

    Published 2024
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  6. 6
    In Vivo Response to Methotrexate Forecasts Outcome of Acute Lymphoblastic Leukemia and Has a Distinct Gene Expression Profile

    In Vivo Response to Methotrexate Forecasts Outcome of Acute Lymphoblastic Leukemia and Has a Distinct Gene Expression Profile by Michael J. Sorich, Nicolas Pottier, Deqing Pei, Wenjian Yang, Leo Kager, Gabriele Stocco, Cheng Cheng, John C. Panetta, Ching‐Hon Pui, Mary V. Relling, Meyling Cheok, William E. Evans

    Published 2008
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  7. 7
    Identification of genes associated with chemotherapy crossresistance and treatment response in childhood acute lymphoblastic leukemia

    Identification of genes associated with chemotherapy crossresistance and treatment response in childhood acute lymphoblastic leukemia by Sanne Lugthart, Meyling Cheok, Monique L. den Boer, Wenjian Yang, Amy de Haar-Holleman, Cheng Cheng, Ching‐Hon Pui, Mary V. Relling, Gritta Janka‐Schaub, Rob Pieters, William E. Evans

    Published 2005
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  8. 8
    The SWI/SNF Chromatin-Remodeling Complex and Glucocorticoid Resistance in Acute Lymphoblastic Leukemia

    The SWI/SNF Chromatin-Remodeling Complex and Glucocorticoid Resistance in Acute Lymphoblastic Leukemia by Nicolas Pottier, Wenjian Yang, Mahfoud Assem, John C. Panetta, Deqing Pei, Steven W. Paugh, Cheng Cheng, Monique L. den Boer, Mary V. Relling, Rob Pieters, William E. Evans, Meyling Cheok

    Published 2008
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  9. 9
    Thiopurine pathway

    Thiopurine pathway by Gianluigi Zaza, Meyling Cheok, Natalia F. Krynetskaia, Caroline F. Thorn, Gabriele Stocco, Joan M. Hebert, Howard L. McLeod, Richard M. Weinshilboum, Mary V. Relling, William E. Evans, Teri E. Klein, Russ B. Altman

    Published 2010
    Get full text
    Artigo
    Save to List
    Saved in:
  10. 10
    Defective NK Cells in Acute Myeloid Leukemia Patients at Diagnosis Are Associated with Blast Transcriptional Signatures of Immune Evasion

    Defective NK Cells in Acute Myeloid Leukemia Patients at Diagnosis Are Associated with Blast Transcriptional Signatures of Immune Evasion by Zena Khaznadar, Nicolas Boissel, Sophie Agaugué, Guylaine Henry, Meyling Cheok, Marguerite Vignon, Daniela Géromin, Jean‐Michel Cayuela, Sylvie Castaigné, Cécile Pautas, Emmanuel Raffoux, Joël Lachuer, François Sigaux, Claude Preudhomme, Hervé Dombret, Nicolas Dulphy, Antoine Toubert

    Published 2015
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  11. 11
    Gene-Expression Patterns in Drug-Resistant Acute Lymphoblastic Leukemia Cells and Response to Treatment

    Gene-Expression Patterns in Drug-Resistant Acute Lymphoblastic Leukemia Cells and Response to Treatment by Amy de Haar-Holleman, Meyling Cheok, Monique L. den Boer, Wenjian Yang, A. Veerman, Karin M. Kazemier, Deqing Pei, Cheng Cheng, Ching‐Hon Pui, Mary V. Relling, Gritta Janka‐Schaub, Rob Pieters, William E. Evans

    Published 2004
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  12. 12
    Clinical impact of gene mutations and lesions detected by SNP-array karyotyping in acute myeloid leukemia patients in the context of gemtuzumab ozogamicin treatment: Results of the ALFA-0701 trial

    Clinical impact of gene mutations and lesions detected by SNP-array karyotyping in acute myeloid leukemia patients in the context of gemtuzumab ozogamicin treatment: Results of the... by Aline Renneville, Raouf Ben Abdelali, Sylvie Chevret, Olivier Nibourel, Meyling Cheok, Cécile Pautas, Rémy Dulery, Thomas Boyer, Jean‐Michel Cayuela, Sandrine Hayette, Emmanuel Raffoux, H. Farhat, Nicolas Boissel, Christine Terré, Hervé Dombret, Sylvie Castaigné, Claude Preudhomme

    Published 2014
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  13. 13
    Transporter-Mediated Protection against Thiopurine-Induced Hematopoietic Toxicity

    Transporter-Mediated Protection against Thiopurine-Induced Hematopoietic Toxicity by Partha Krishnamurthy, Matthias Schwab, Kazumasa Takenaka, Deepa Nachagari, James P. Morgan, Mark Leslie, Weinan Du, Kelli L. Boyd, Meyling Cheok, Hiromitsu Nakauchi, Catia Marzolini, Richard B. Kim, Poonkuzhali Balasubramanian, Erin G. Schuetz, William E. Evans, Mary V. Relling, John D. Schuetz

    Published 2008
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  14. 14
    <i>Neurofibromatosis‐1</i> gene deletions and mutations in de novo adult acute myeloid leukemia

    <i>Neurofibromatosis‐1</i> gene deletions and mutations in de novo adult acute myeloid leukemia by Elise Boudry‐Labis, Catherine Roche‐Lestienne, Olivier Nibourel, Nicolas Boissel, Christine Terré, Christine Pérot, Virginie Éclache, Nathalie Gachard, Isabelle Tigaud, Ghislaine Plessis, Wendy Cuccuini, Sandrine Geffroy, Céline Villenet, Martin Figeac, Frédéric Leprêtre, Aline Renneville, Meyling Cheok, Jean Soulier, Hervé Dombret, Claude Preudhomme

    Published 2013
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  15. 15
    Incidence and prognostic value of TET2 alterations in de novo acute myeloid leukemia achieving complete remission

    Incidence and prognostic value of TET2 alterations in de novo acute myeloid leukemia achieving complete remission by Olivier Nibourel, Olivier Kosmider, Meyling Cheok, Nicolas Boissel, Aline Renneville, N Philippe, Hervé Dombret, François Dreyfus, Bruno Quesnel, Sandrine Geffroy, Samuel Quentin, Catherine Roche‐Lestienne, Jean‐Michel Cayuela, Christophe Roumier, Pierre Fenaux, William Vainchenker, Olivier Bernard, Jean Soulier, Michaëla Fontenay, Claude Preudhomme

    Published 2010
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  16. 16
    Somatic deletions of genes regulating MSH2 protein stability cause DNA mismatch repair deficiency and drug resistance in human leukemia cells

    Somatic deletions of genes regulating MSH2 protein stability cause DNA mismatch repair deficiency and drug resistance in human leukemia cells by B Diouf, Qing Cheng, Natalia F. Krynetskaia, Wenjian Yang, Meyling Cheok, Deqing Pei, Yiping Fan, Cheng Cheng, Evgeny Krynetskiy, Hui Geng, Siying Chen, William E. Thierfelder, Charles G. Mullighan, James R. Downing, Peggy Hsieh, Ching‐Hon Pui, Mary V. Relling, William E. Evans

    Published 2011
    Get full text
    Artigo
    Save to List
    Saved in:
  17. 17
    <i>IDH1/2</i>but not<i>DNMT3A</i>mutations are suitable targets for minimal residual disease monitoring in acute myeloid leukemia patients: a study by the Acute Leukemia French Association

    <i>IDH1/2</i>but not<i>DNMT3A</i>mutations are suitable targets for minimal residual disease monitoring in acute myeloid leukemia patients: a study by the Acute Leukemia French Ass... by Houria Debarri, Delphine Lebon, Christophe Roumier, Meyling Cheok, Alice Marceau‐Renaut, Olivier Nibourel, Sandrine Geffroy, Nathalie Hélevaut, Philippe Rousselot, Bérengère Gruson, Claude Gardin, Marie‐Lorraine Chrétien, Shéhérazade Sebda, Martin Figeac, Céline Berthon, Bruno Quesnel, Nicolas Boissel, Sylvie Castaigné, Hervé Dombret, Aline Renneville, Claude Preudhomme

    Published 2015
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  18. 18
    Mutational profile and benefit of gemtuzumab ozogamicin in acute myeloid leukemia

    Mutational profile and benefit of gemtuzumab ozogamicin in acute myeloid leukemia by Élise Fournier, Nicolas Duployez, Benoît Ducourneau, Emmanuel Raffoux, Pascal Turlure, Denis Caillot, Xavier Thomas, Alice Marceau‐Renaut, Sylvain Chantepie, Jean‐Valère Malfuson, Émilie Lemasle, Meyling Cheok, Karine Celli‐Lebras, Estelle Guérin, Christine Terré, Juliette Lambert, Cécile Pautas, Hervé Dombret, Sylvie Castaigné, Claude Preudhomme, Nicolas Boissel

    Published 2019
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  19. 19
    A cellular hierarchy framework for understanding heterogeneity and predicting drug response in acute myeloid leukemia

    A cellular hierarchy framework for understanding heterogeneity and predicting drug response in acute myeloid leukemia by Andy G.X. Zeng, Suraj Bansal, Liqing Jin, Amanda Mitchell, Weihsu Claire Chen, Hussein A. Abbas, Michelle Chan‐Seng‐Yue, Véronique Voisin, Peter van Galen, Anne Tierens, Meyling Cheok, Claude Preudhomme, Hervé Dombret, Naval Daver, P. Andrew Futreal, Mark D. Minden, James A. Kennedy, Jean Wang, John E. Dick

    Published 2022
    Get full text
    Artigo
    Save to List
    Saved in:
  20. 20
    TET2 mutation is an independent favorable prognostic factor in myelodysplastic syndromes (MDSs)

    TET2 mutation is an independent favorable prognostic factor in myelodysplastic syndromes (MDSs) by Olivier Kosmider, Véronique Gelsi‐Boyer, Meyling Cheok, Sophie Grabar, Véronique Della-Valle, Françoise Picard, F Viguié, Bruno Quesnel, Odile Beyne‐Rauzy, Éric Solary, Norbert Vey, Mathilde Hunault, Pierre Fenaux, Véronique Mansat‐De Mas, Éric Delabesse, Philippe Guardiola, Catherine Lacombe, William Vainchenker, Claude Preudhomme, François Dreyfus, Olivier Bernard, Daniel Birnbaum, Michaëla Fontenay

    Published 2009
    Get full text Get full text
    Artigo
    Save to List
    Saved in:

Search Tools: